Humzah A. Quereshy

Jul 16, 2024 | onlinelibrary.wiley.com | Anu Sharma |Humzah A. Quereshy |Claudia Cabrera |Nicole Fowler

1 INTRODUCTION Concurrent chemoradiation is commonly used to definitively treat locally advanced head and neck squamous cell cancers (HNSCC).1, 2 At many institutions, the standard of care is to conduct a post-treatment Fluorine-18-Fluorodeoxyglucose (18F-FDG) Positron-Emission Tomography/Computed Tomography (PET/CT) 3 months following completion of concurrent chemoradiation as a measure of response to therapy.3, 4 18F-FDG is an analog of glucose; therefore, its uptake in lymph nodes suggests...